Alan Brian Collier
Net Worth
Last updated:
What is Alan Brian Collier net worth?
The estimated net worth of Mr. Alan Brian Collier is at least $1,800,005 as of 1 Jul 2020. He owns shares worth $5 as insider and has received compensation worth at least $1,800,000 in Endonovo Therapeutics, Inc..
What is the salary of Alan Brian Collier?
Mr. Alan Brian Collier salary is $300,000 per year as Chairman, Chief Executive Officer, Interim Chief Financial Officer & Sec. in Endonovo Therapeutics, Inc..
How old is Alan Brian Collier?
Mr. Alan Brian Collier is 59 years old, born in 1966.
What stocks does Alan Brian Collier currently own?
As insider, Mr. Alan Brian Collier owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Endonovo Therapeutics, Inc. (ENDV) | Chairman, Chief Executive Officer, Interim Chief Financial Officer & Sec. | 26,119 | $0 | $5 |
What does Endonovo Therapeutics, Inc. do?
Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema. Its Electroceuticals medical device is also used for the treatment of inflammation, wounds, cardiovascular diseases, chronic kidney diseases, liver diseases, non-alcoholic steatohepatitis, peripheral artery diseases, and ischemic stroke, as well as for central nervous system disorders, such as traumatic brain injury, acute concussions, post-concussion syndrome, and multiple sclerosis. Endonovo Therapeutics, Inc. was founded in 2008 and is based in Woodland Hills, California.
Alan Brian Collier insider trading
Endonovo Therapeutics, Inc.
Endonovo Therapeutics key executives
Endonovo Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Mr. Alan Brian Collier (59) Chairman, Chief Executive Officer, Interim Chief Financial Officer & Sec.